| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| R&D Expense | $9.3M | -59.9% |
| SG&A Expense | $8.6M | -3.2% |
| Operating Income | -$18.1M | +43.9% |
| Interest Expense | $312K | -89.2% |
| Net Income | -$17.5M | +45.4% |
| EPS (Basic) | -$12.12 | -66.0% |
| EPS (Diluted) | -$12.12 | -66.0% |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $17.5M | -26.4% |
| Current Assets | $20.7M | -13.9% |
| Total Assets | $21.6M | -14.5% |
| Current Liabilities | $2.3M | -75.7% |
| Total Liabilities | $2.6M | -73.7% |
| Stockholders' Equity | $19.0M | +22.6% |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$19.0M | +31.9% |
| Investing Cash Flow | $14.5M | +0.0% |
| Financing Cash Flow | $12.7M | -28.5% |